Details
Stereochemistry | RACEMIC |
Molecular Formula | C6H9NO2S |
Molecular Weight | 159.206 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(=O)NC1CCSC1=O
InChI
InChIKey=NRFJZTXWLKPZAV-UHFFFAOYSA-N
InChI=1S/C6H9NO2S/c1-4(8)7-5-2-3-10-6(5)9/h5H,2-3H2,1H3,(H,7,8)
Molecular Formula | C6H9NO2S |
Molecular Weight | 159.206 |
Charge | 0 |
Count |
|
Stereochemistry | RACEMIC |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Optical Activity | ( + / - ) |
CNS Activity
Sources: https://www.ncbi.nlm.nih.gov/pubmed/2616067 | https://www.ncbi.nlm.nih.gov/pubmed/3034565
Curator's Comment: Citiolone is neuroprotective in animals. No human data available.
Originator
Sources: https://encrypted.google.com/patents/DE1134683B
Curator's Comment: reference retrieved from http://www.drugfuture.com/chemdata/citiolone.html
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: WP408 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | REDUCDYN Approved UseReducdyn (Citiolone + L-Cysteine) is used for acute hepatitis, infections and toxic liver diseases, intoxications, side effects of irradiation, Allergic dermatoses, pruritis. |
Sample Use Guides
Reducdyn (Citiolone 50mg/tab. + L-Cysteine 50mg/tab): 3 tablets 3 times daily, to be swallowed whole with some liquid during or immediately after meals.
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/9301047
Human skin fibroblasts were irradiated following incubation with N-acetyl-homocysteine-thiolactone (citiolone (CIT), 1 mM). Treatments with CIT resulted in a significant rise in glutathione levels compared with control cells, with protection against UVA radiation.
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 16:01:36 GMT 2023
by
admin
on
Fri Dec 15 16:01:36 GMT 2023
|
Record UNII |
70JKL15MUH
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C29767
Created by
admin on Fri Dec 15 16:01:36 GMT 2023 , Edited by admin on Fri Dec 15 16:01:36 GMT 2023
|
||
|
WHO-VATC |
QA05BA04
Created by
admin on Fri Dec 15 16:01:36 GMT 2023 , Edited by admin on Fri Dec 15 16:01:36 GMT 2023
|
||
|
NCI_THESAURUS |
C2081
Created by
admin on Fri Dec 15 16:01:36 GMT 2023 , Edited by admin on Fri Dec 15 16:01:36 GMT 2023
|
||
|
WHO-ATC |
A05BA04
Created by
admin on Fri Dec 15 16:01:36 GMT 2023 , Edited by admin on Fri Dec 15 16:01:36 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
m3589
Created by
admin on Fri Dec 15 16:01:36 GMT 2023 , Edited by admin on Fri Dec 15 16:01:36 GMT 2023
|
PRIMARY | Merck Index | ||
|
C77426
Created by
admin on Fri Dec 15 16:01:36 GMT 2023 , Edited by admin on Fri Dec 15 16:01:36 GMT 2023
|
PRIMARY | |||
|
14520
Created by
admin on Fri Dec 15 16:01:36 GMT 2023 , Edited by admin on Fri Dec 15 16:01:36 GMT 2023
|
PRIMARY | |||
|
C000486
Created by
admin on Fri Dec 15 16:01:36 GMT 2023 , Edited by admin on Fri Dec 15 16:01:36 GMT 2023
|
PRIMARY | |||
|
CITIOLONE
Created by
admin on Fri Dec 15 16:01:36 GMT 2023 , Edited by admin on Fri Dec 15 16:01:36 GMT 2023
|
PRIMARY | |||
|
DB13442
Created by
admin on Fri Dec 15 16:01:36 GMT 2023 , Edited by admin on Fri Dec 15 16:01:36 GMT 2023
|
PRIMARY | |||
|
21171
Created by
admin on Fri Dec 15 16:01:36 GMT 2023 , Edited by admin on Fri Dec 15 16:01:36 GMT 2023
|
PRIMARY | RxNorm | ||
|
70JKL15MUH
Created by
admin on Fri Dec 15 16:01:36 GMT 2023 , Edited by admin on Fri Dec 15 16:01:36 GMT 2023
|
PRIMARY | |||
|
100000084596
Created by
admin on Fri Dec 15 16:01:36 GMT 2023 , Edited by admin on Fri Dec 15 16:01:36 GMT 2023
|
PRIMARY | |||
|
2677
Created by
admin on Fri Dec 15 16:01:36 GMT 2023 , Edited by admin on Fri Dec 15 16:01:36 GMT 2023
|
PRIMARY | |||
|
CHEMBL2104457
Created by
admin on Fri Dec 15 16:01:36 GMT 2023 , Edited by admin on Fri Dec 15 16:01:36 GMT 2023
|
PRIMARY | |||
|
SUB06633MIG
Created by
admin on Fri Dec 15 16:01:36 GMT 2023 , Edited by admin on Fri Dec 15 16:01:36 GMT 2023
|
PRIMARY | |||
|
665
Created by
admin on Fri Dec 15 16:01:36 GMT 2023 , Edited by admin on Fri Dec 15 16:01:36 GMT 2023
|
PRIMARY | |||
|
214-793-8
Created by
admin on Fri Dec 15 16:01:36 GMT 2023 , Edited by admin on Fri Dec 15 16:01:36 GMT 2023
|
PRIMARY | |||
|
22878
Created by
admin on Fri Dec 15 16:01:36 GMT 2023 , Edited by admin on Fri Dec 15 16:01:36 GMT 2023
|
PRIMARY | |||
|
DTXSID0045888
Created by
admin on Fri Dec 15 16:01:36 GMT 2023 , Edited by admin on Fri Dec 15 16:01:36 GMT 2023
|
PRIMARY | |||
|
1195-16-0
Created by
admin on Fri Dec 15 16:01:36 GMT 2023 , Edited by admin on Fri Dec 15 16:01:36 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ENANTIOMER -> RACEMATE | |||
|
ENANTIOMER -> RACEMATE |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |